Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FVMJ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,908
Award facts
- Contract value 100% obligated
- $16,907.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,907.62 on September 24, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. The order is scheduled for completion by September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency Medical Supply Chain, positioning the company as a critical vendor for federal medical procurement across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FVMJ4?
SPE2DB25FVMJ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FVMJ4 worth?
The government has obligated $16,908 on SPE2DB25FVMJ4.
Is contract SPE2DB25FVMJ4 an order under another contract?
Yes. SPE2DB25FVMJ4 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVMJ4 competed?
The extent of competition for SPE2DB25FVMJ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award